Figure 1From: Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary reportThe serial change in glucose (A), triglyceride (TG) (B), remnant lipoprotein cholesterol (RLP-C) (C), apolipoprotein B-48 (ApoB-48) (D), glucagon-like peptide-1 (GLP-1) (E), and glucagon (F). *p<0.05 vs. control group.Back to article page